Tuesday, 16 June 2020

Nanotechnology-enabled approaches against COVID-19

Nanotechnology can play its part in the fight against the COVID-19 pandemic. More than a dozen scientists, including ICREA Prof. Arben Merkoçi, Group Leader at the ICN2, have analysed the role of nanotechnology in prevention, therapeutics, diagnostics and other facets needed to address this and future pandemics.

Thursday, 11 June 2020

New investors for INBRAIN to develop graphene-based implants against brain disorders

INBRAIN Neuroelectronics, a spin-off of the Catalan Institute of Nanoscience and Nanotechnology and ICREA, receives funding from Sabadell Asabys and Alta Life Sciences, as well as ICF and Finaves, which will allow the company to speed up the development of novel graphene-based implants to optimise the treatment of brain disorders, such as Parkinson's and epilepsy.